We were contacted by the family of Suzanne, a 19-year-old girl from France, with a diagnosis of residual encephalopathy, likely of neuroinflammatory and hypoxic
origin, pronounced speech and cognitive developmental delay, and traits of autism spectrum disorder.

Suzanne's social adaptation is limited, which causes some difficulty and concern for her elderly parents, who are finding it increasingly hard to care for their daughter. That's why they reached out to us for help.

🔗In April, Suzanne underwent a combined protocol (HSCs, MSCs, and exosomes) in Samara.

Her parents shared an interim testimonial with us!

📎 Before biotherapy, the concerns were: difficult social adaptation, not following her parents' requests, being easily distracted, not listening at all, disorientation outdoors, and being unable to leave her alone.

After biotherapy: there are no dramatic behavioral changes at this point, but there are changes in the cognitive sphere. She has become more independent in doing household tasks and in other activities. She reacts and adjusts her behavior faster in response to instructions and prompts, which was never the case before.
She has also started noticing the model she's drawing from and copying it onto paper, which points to positive changes in her cognitive function.

📎 Photo 1, before biotherapy. This drawing is typical of what Suzanne has been drawing for a long time now: lots of small circles of different sizes and colors.

Photo 2, after biotherapy. This is a tree she drew in her own way, copying a model her parents showed her.

We'll continue following Suzanne's progress!